A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

NCT00227227 ·Status: COMPLETED

Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study

NCT02687620 ·Status: UNKNOWN

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

NCT02685904 ·Status: TERMINATED ·Phase: PHASE3

Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis

NCT02638896 ·Status: UNKNOWN ·Phase: PHASE4

Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

NCT01188655 ·Status: COMPLETED

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

NCT01258738 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

NCT00953979 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

NCT00421915 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

NCT01298531 ·Status: COMPLETED ·Phase: PHASE4

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

NCT00558506 ·Status: UNKNOWN ·Phase: PHASE2

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

NCT01934933 ·Status: COMPLETED ·Phase: PHASE4

Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs

NCT04139954 ·Status: UNKNOWN

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

NCT03457792 ·Status: COMPLETED

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

NCT00434044 ·Status: COMPLETED ·Phase: PHASE3

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

NCT01578850 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain

NCT00873730 ·Status: COMPLETED ·Phase: PHASE4

Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs

NCT04077957 ·Status: UNKNOWN ·Phase: PHASE4

To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS

NCT02311842 ·Status: COMPLETED

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

NCT00418548 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

NCT01411215 ·Status: TERMINATED

Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

NCT00458185 ·Status: COMPLETED ·Phase: PHASE4

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

NCT00503503 ·Status: COMPLETED

16.0040 Ankylosing Spondylitis Study

NCT00356356 ·Status: COMPLETED ·Phase: PHASE3